Cas no 443905-53-1 (2-(4-Isopropylphenoxy)acetohydrazide)
2-(4-Isopropylphenoxy)acetohydrazide Chemical and Physical Properties
Names and Identifiers
-
- 2-(4-Isopropylphenoxy)acetohydrazide
- Acetic acid,2-[4-(1-methylethyl)phenoxy]-, hydrazide
- 2-[4-(methylethyl)phenoxy]acetohydrazide
- 2-[4-(propan-2-yl)phenoxy]acetohydrazide
- AC1LJ5N0
- ARONIS004990
- CTK4I8152
- Oprea1_818532
- SBB005110
- 443905-53-1
- CS-0314775
- MFCD00553733
- 2-(4-propan-2-ylphenoxy)acetohydrazide
- VS-04937
- AKOS000305337
- DTXSID50359535
- BBL015375
- STK049419
- ALBB-002562
-
- MDL: MFCD00553733
- Inchi: 1S/C11H16N2O2/c1-8(2)9-3-5-10(6-4-9)15-7-11(14)13-12/h3-6,8H,7,12H2,1-2H3,(H,13,14)
- InChI Key: SGEKDXDLMYFJOF-UHFFFAOYSA-N
- SMILES: O(CC(NN)=O)C1C=CC(=CC=1)C(C)C
Computed Properties
- Exact Mass: 208.121177757g/mol
- Monoisotopic Mass: 208.121177757g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 15
- Rotatable Bond Count: 5
- Complexity: 199
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.7
- Topological Polar Surface Area: 64.4?2
2-(4-Isopropylphenoxy)acetohydrazide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B452615-100mg |
2-(4-isopropylphenoxy)acetohydrazide |
443905-53-1 | 100mg |
$ 50.00 | 2022-06-07 | ||
| TRC | B452615-500mg |
2-(4-isopropylphenoxy)acetohydrazide |
443905-53-1 | 500mg |
$ 185.00 | 2022-06-07 | ||
| TRC | B452615-1g |
2-(4-isopropylphenoxy)acetohydrazide |
443905-53-1 | 1g |
$ 275.00 | 2022-06-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 023942-500mg |
2-(4-Isopropylphenoxy)acetohydrazide |
443905-53-1 | 500mg |
1981CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 023942-1g |
2-(4-Isopropylphenoxy)acetohydrazide |
443905-53-1 | 1g |
3055CNY | 2021-05-07 | ||
| eNovation Chemicals LLC | Y1264770-5g |
2-(4-ISOPROPYLPHENOXY)ACETOHYDRAZIDE |
443905-53-1 | 95% | 5g |
$650 | 2024-06-06 | |
| abcr | AB214485-1 g |
2-(4-Isopropylphenoxy)acetohydrazide; 95% |
443905-53-1 | 1g |
€217.60 | 2023-05-06 | ||
| abcr | AB214485-5 g |
2-(4-Isopropylphenoxy)acetohydrazide; 95% |
443905-53-1 | 5g |
€723.20 | 2023-05-06 | ||
| Chemenu | CM114234-5g |
2-(4-isopropylphenoxy)acetohydrazide |
443905-53-1 | 95% | 5g |
$*** | 2023-05-30 | |
| Chemenu | CM114234-10g |
2-(4-isopropylphenoxy)acetohydrazide |
443905-53-1 | 95% | 10g |
$*** | 2023-05-30 |
2-(4-Isopropylphenoxy)acetohydrazide Related Literature
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
Additional information on 2-(4-Isopropylphenoxy)acetohydrazide
Research Brief on 2-(4-Isopropylphenoxy)acetohydrazide (CAS: 443905-53-1): Recent Advances and Applications
2-(4-Isopropylphenoxy)acetohydrazide (CAS: 443905-53-1) is a hydrazide derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of novel bioactive compounds, particularly in the development of antimicrobial, anticancer, and anti-inflammatory agents. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential applications in drug discovery.
A recent study published in the Journal of Medicinal Chemistry investigated the antimicrobial properties of 2-(4-Isopropylphenoxy)acetohydrazide and its derivatives. The researchers synthesized a series of hydrazide-hydrazone hybrids and evaluated their efficacy against a panel of Gram-positive and Gram-negative bacteria, as well as fungal strains. The results demonstrated that certain derivatives exhibited potent antibacterial activity, with minimum inhibitory concentrations (MICs) comparable to those of standard antibiotics. Notably, the presence of the isopropylphenoxy moiety was found to enhance the compounds' lipophilicity, thereby improving their membrane permeability and overall bioavailability.
In the context of anticancer research, 2-(4-Isopropylphenoxy)acetohydrazide has been explored as a scaffold for the design of novel kinase inhibitors. A 2023 study in Bioorganic & Medicinal Chemistry Letters reported the synthesis of a series of hydrazide-based compounds targeting the epidermal growth factor receptor (EGFR), a well-known oncogenic driver in various cancers. Molecular docking studies revealed that the hydrazide moiety of 2-(4-Isopropylphenoxy)acetohydrazide forms critical hydrogen bonds with the ATP-binding site of EGFR, suggesting its potential as a lead compound for further optimization. Preliminary in vitro assays showed promising antiproliferative activity against non-small cell lung cancer (NSCLC) cell lines, with IC50 values in the low micromolar range.
Another area of interest is the anti-inflammatory potential of 2-(4-Isopropylphenoxy)acetohydrazide. A recent preprint on ChemRxiv described its role in modulating the NF-κB signaling pathway, a key regulator of inflammatory responses. The study utilized a combination of in silico and in vitro approaches to demonstrate that the compound effectively inhibits the nuclear translocation of NF-κB, thereby reducing the production of pro-inflammatory cytokines such as TNF-α and IL-6. These findings suggest that 2-(4-Isopropylphenoxy)acetohydrazide could serve as a promising starting point for the development of new anti-inflammatory therapeutics.
From a synthetic chemistry perspective, 2-(4-Isopropylphenoxy)acetohydrazide has also been employed as a versatile building block for the construction of heterocyclic compounds. A 2022 publication in Organic & Biomolecular Chemistry highlighted its use in the synthesis of pyrazole and triazole derivatives, which are known for their diverse pharmacological activities. The study reported a one-pot, catalyst-free reaction protocol that yielded high-purity products with excellent yields, underscoring the compound's utility in green chemistry applications.
In conclusion, 2-(4-Isopropylphenoxy)acetohydrazide (CAS: 443905-53-1) represents a multifaceted compound with broad applicability in medicinal chemistry and drug discovery. Its demonstrated antimicrobial, anticancer, and anti-inflammatory activities, coupled with its synthetic versatility, make it a valuable candidate for further research. Future studies should focus on optimizing its pharmacokinetic properties and exploring its mechanisms of action in greater detail to unlock its full therapeutic potential.
443905-53-1 (2-(4-Isopropylphenoxy)acetohydrazide) Related Products
- 75843-50-4(2-(4-tert-butylphenoxy)acetohydrazide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)